Foli-seq™ Platform Applications
Gastrointestinal Diseases (IBD, IBS, CRC)
Pre-clinical/TranslationalActive
Key Facts
Indication
Gastrointestinal Diseases (IBD, IBS, CRC)
Phase
Pre-clinical/Translational
Status
Active
Company
About Foli Bio
Foli Bio is a private, pre-revenue biotech startup founded in 2021 and based in San Diego, CA. The company has developed Foli-seq™, a proprietary platform for non-invasive transcriptomic profiling of the gut using RNA from stool, aiming to unlock insights into gut health and disease. It is actively building collaborations with academic institutions and pharmaceutical companies to advance precision diagnostics and biomarker discovery for gastrointestinal conditions. The company is in a platform validation and partnership development stage.
View full company profile